In vitro diagnostic products

FDA Guidance for Industry on the Content and Format of Chemistry, Manufacturing, and Controls and Establishment Description Information for a Biological In Vitro Diagnostic Product (March 1999)... 

The medical devices for category 2 in Table 1 are composed in batch. Process validation should be a key factor in manufacturing uniform products. In this category, sterile products, such as central venous catheters and ophthalmic viscosurgical solution without pharmacological and metabolic action, are involved. In vitro diagnostic products are also involved in this category. 

It is estimated that by 2015, many in vitro diagnostic products (IVD) analyses for both the lab and point-of-care will be based on miniaturized and multiplexed technologies, for example, chip technologies (Kalorama, 2008 Matsson, 2008). 

In vivo diagnostic agents are medicines, while in vitro diagnostic products are mediccd devices (except pregnancy test kits, which are medicines). 

Includes information for medical devices general, labeling, reporting, in vitro diagnostic products, investigational device exemptions, premarket approval, postmarket surveillance, and classification procedures. 

Medical Device Technology. UK Advanstar Communications Ltd. ISSN 1096-1801. Technical information on all aspects of the design, production and manufacture of finished medical devices and in vitro diagnostic products. European focus. Free to qualified readers in Europe. 

IVD Technology (Written exclusively for original equipment manufacturers of in vitro diagnostic products)... 

The sampling kit consists of the labelled urea, which is a drug a sampling straw, which is a device and a sample container, which would be considered an in-vitro diagnostic (IVD) medical device under EU definitions. Other examples of diagnostic drug products used in conjunction with medical devices include dyes administered to visualise blocked veins and arteries. 

CAUTION Contains a biological product for investigational in-vitro diagnostic tests only . 

In-vitro diagnostic reagents for field trial studies should bear the statement For Investigational Use Only. The performance characteristics of this product have not been established. ... 

Recent developments in Europe mean that reference materials included in diagnostic kits are covered by the recent directive controlling the production and use of in vitro diagnostic devices, and must be licensed before use. 

Product label research use Product label investigational use Product label in vitro diagnostic use... 

Directive 98/79/EC on in vitro diagnostics (TVDs ) came into force on 7 June 2000 and is mandatory from 7 December 2003. This covers products such as pregnancy tests, blood glucose monitoring and tests for transmissible diseases. 

The In-Vitro-Diagnostic (IVD)-Directive [1] requires manufacturers to assure traceability of assigned values to calibrators and trueness control materials to reference measurement procedures and/or reference materials of a higher order, where available. This is a legal requirement for products marketed in Europe, and manufacturers are interested in applying the principle of traceability on a global scale, because it allows products to be marketed world-wide. The benefit to patients and users is perceived as the direct comparability of laboratory measurement results over regions and time. 

Regulatory Status of the Primary Antibody Intended use For in vitro diagnostic use. Indicates that a product meets the FDA reguirements as a clinical diagnostic product. Likewise, a CE icon indicates the reagent meets European Union reguirements. Patient test results do not reguire an FDA disclaimer. 

For residues (such as cleaning agents) that do not have a defined dose, some measure of toxicity, such as an acceptable daily intake (ADI), is used for residue limit purposes. If the subsequently manufactured product is an in vitro diagnostic (IVD), and has no defined dose, then some evaluation of the effects of target residues on the performance or stability of the IVD product should be performed. These non-dose factors are used only for the Li limit there are no changes for calculation of L2 and L3 limits. 

The term medical device is defined under section 2 of the Medicines Act 1981 and includes any device, instrument or apparatus (or its component parts) which is used principally in humans for a therapeutic purpose. It includes bandages and in vitro diagnostic agents. It should be noted that a number of products are defined as medicines in New Zealand which in other countries are controlled as medical devices (e.g., pregnancy test kits). 

In vitro diagnostic (IVD) products These are medical devices which analyze human body fluids, such as blood or urine, to provide information for the diagnosis, prevention, or treatment of a disease. Classification for these devices can be found under 21 CER 862, 21 CER 86 , and 21 CER 866. 

Community on In-Vitro Diagnostics) is a European legislative regulation directed at in vitro manufacturers. The directive demands that the manufacturer have a quality management system and that products are validated by competent laboratories. It is required that the traceability of values assigned to calibrators or control materials or both must be ensured through available reference measurement procedures and/or available materials of higher order. Explicit statement of the uncertainty of calibrator values is not required, but indirectly the manufacturers have to... 

---